ROCKWELL MEDICAL INC (RMTI) Stock Earnings Estimates
NASDAQ:RMTI • US7743743004
1.02 USD
+0.01 (+0.99%)
Last: Feb 17, 2026, 12:47 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 72.81M 17.57% | 83.612M 14.84% | 101.489M 21.38% | 70.883M -30.16% | 76.656M 8.14% | 79.475M 3.68% | N/A | |
| EBITDA YoY % growth | -16.2M 45.40% | -5.226M 67.74% | 2.788M 153.35% | 1.033M -62.95% | 2.832M 174.15% | 3.983M 40.64% | N/A | |
| EBIT YoY % growth | -16.78M 44.69% | -6.67M 60.25% | 608K 109.12% | -4.924M -909.79% | -2.141M 56.52% | -459K 78.56% | 12.75M 2,877.78% | |
| Operating Margin | -23.05% | -7.98% | 0.60% | -6.95% | -2.79% | -0.58% | N/A | |
| EPS YoY % growth | -2.00 29.58% | -0.40 80.00% | -0.02 94.75% | -0.16 -652.86% | -0.06 64.52% | -0.04 27.27% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -2.00% | -0.04 10.75% | -0.03 38.80% | -0.02 59.20% | -0.02 |
| Revenue Q2Q % growth | 18.953M -23.16% | 18.103M -4.29% | 18.227M 13.42% | 18.674M 17.25% | 19.343M 2.06% |
| EBITDA Q2Q % growth | 1.618M -2.59% | -271.32K 66.95% | 11.22K 104.54% | 98.94K -82.40% | 176.46K -89.09% |
| EBIT Q2Q % growth | -544.68K -4.95% | -1.508M -10.85% | -1.185M 12.14% | -1.094M -0.96% | -1.099M -101.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.05 -200.00% | -0.05 | 0.00 | -8.93% |
| Q2 2025 Q2Q % growth | -0.05 -655.56% | -0.05 | 0.00 | 1.96% |
| Q1 2025 Q2Q % growth | -0.04 33.33% | -0.05 | 0.01 | 21.57% |
| Q4 2024 Q2Q % growth | -0.02 60.00% | 0.02 | -0.04 | -198.04% |
| Q3 2024 Q2Q % growth | 0.05 171.43% | 0.01 | 0.04 | 390.20% |
| Q2 2024 Q2Q % growth | 0.01 105.00% | -0.04 | 0.04 | 125.21% |
| Q1 2024 Q2Q % growth | -0.06 40.00% | -0.04 | -0.02 | -47.06% |
| Q4 2023 Q2Q % growth | -0.05 75.00% | -0.07 | 0.02 | 29.97% |
| Q3 2023 Q2Q % growth | -0.07 82.50% | -0.11 | 0.04 | 34.64% |
| Q2 2023 Q2Q % growth | -0.18 67.86% | -0.12 | -0.06 | -47.06% |
| Q1 2023 Q2Q % growth | -0.10 88.10% | -0.17 | 0.07 | 40.58% |
| Q4 2022 Q2Q % growth | -0.20 -122.22% | -0.40 | 0.20 | 49.72% |
| Q3 2022 Q2Q % growth | -0.40 54.55% | -0.49 | 0.09 | 19.14% |
| Q2 2022 Q2Q % growth | -0.56 43.43% | -0.83 | 0.27 | 32.22% |
| Q1 2022 Q2Q % growth | -0.84 4.55% | -1.01 | 0.17 | 16.82% |
| Q4 2021 Q2Q % growth | -0.09 90.91% | -1.01 | 0.92 | 91.09% |
| Q3 2021 Q2Q % growth | -0.88 20.00% | -0.84 | -0.04 | -4.58% |
| Q2 2021 Q2Q % growth | -0.99 | -0.90 | -0.09 | -10.29% |
| Q1 2021 Q2Q % growth | -0.88 33.33% | -1.01 | 0.13 | 12.85% |
| Q4 2020 Q2Q % growth | -0.99 | -0.95 | -0.04 | -3.81% |
| Q3 2020 Q2Q % growth | -1.10 | -1.12 | 0.02 | 1.96% |
| Q2 2020 Q2Q % growth | -0.99 | -1.57 | 0.58 | 36.97% |
| Q1 2020 Q2Q % growth | -1.32 | -1.38 | 0.06 | 4.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 15.927M -43.75% | 16.566M | -639K | -3.86% |
| Q2 2025 Q2Q % growth | 16.071M -37.79% | 16.659M | -588K | -3.53% |
| Q1 2025 Q2Q % growth | 18.914M -16.59% | 17.809M | 1.105M | 6.20% |
| Q4 2024 Q2Q % growth | 24.665M 11.64% | 24.126M | 539K | 2.23% |
| Q3 2024 Q2Q % growth | 28.316M 19.12% | 27.028M | 1.288M | 4.77% |
| Q2 2024 Q2Q % growth | 25.832M 42.88% | 23.379M | 2.453M | 10.49% |
| Q1 2024 Q2Q % growth | 22.676M 15.29% | 22.138M | 538K | 2.43% |
| Q4 2023 Q2Q % growth | 22.093M 14.41% | 23.087M | -994K | -4.31% |
| Q3 2023 Q2Q % growth | 23.771M 27.19% | 23.302M | 469K | 2.01% |
| Q2 2023 Q2Q % growth | 18.08M -3.21% | 18.439M | -359K | -1.95% |
| Q1 2023 Q2Q % growth | 19.668M 22.01% | 19.499M | 169K | 0.87% |
| Q4 2022 Q2Q % growth | 19.31M 25.96% | 16.638M | 2.672M | 16.06% |
| Q3 2022 Q2Q % growth | 18.69M 16.89% | 19.757M | -1.067M | -5.40% |
| Q2 2022 Q2Q % growth | 18.68M 23.38% | 17.136M | 1.544M | 9.01% |
| Q1 2022 Q2Q % growth | 16.12M 4.20% | 19.176M | -3.056M | -15.94% |
| Q4 2021 Q2Q % growth | 15.33M 1.12% | 18.004M | -2.674M | -14.85% |
| Q3 2021 Q2Q % growth | 15.99M 4.65% | 18.542M | -2.552M | -13.76% |
| Q2 2021 Q2Q % growth | 15.14M -4.78% | 18.58M | -3.44M | -18.51% |
| Q1 2021 Q2Q % growth | 15.47M -2.46% | 17.729M | -2.259M | -12.74% |
| Q4 2020 Q2Q % growth | 15.16M | 15.972M | -812K | -5.08% |
| Q3 2020 Q2Q % growth | 15.28M | 15.986M | -706K | -4.42% |
| Q2 2020 Q2Q % growth | 15.9M | 14.695M | 1.205M | 8.20% |
| Q1 2020 Q2Q % growth | 15.86M | 16.118M | -258K | -1.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 50% | 55.56% | 11.43% | 11.43% |
| Revenue | 12.29% | 8.36% | 3.01% | 1.64% |